Qiang Liu
Fondatore presso Tangent Capital, Inc.
Posizioni attive di Qiang Liu
Società | Posizione | Inizio | Fine |
---|---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Direttore/Membro del Consiglio | 23/11/2009 | - |
Corporate Officer/Principal | 23/11/2009 | 13/04/2012 | |
Tangent Capital, Inc. | Direttore/Membro del Consiglio | 13/12/2010 | - |
Fondatore | 13/12/2010 | - |
Storia della carriera di Qiang Liu
Precedenti posizioni note di Qiang Liu
Società | Posizione | Inizio | Fine |
---|---|---|---|
BCTech Investments, Inc. | Presidente | - | 01/12/2008 |
Formazione di Qiang Liu
York University | Masters Business Admin |
The University of New South Wales | Graduate Degree |
Jilin University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Cina | 4 |
Canada | 3 |
Australia | 2 |
Posizioni
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 4 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Tangent Capital, Inc. | |
BCTech Investments, Inc. |
- Borsa valori
- Insiders
- Qiang Liu
- Esperienza